Michael Peluso, MD (@michaelpelusomd) 's Twitter Profile
Michael Peluso, MD

@michaelpelusomd

Infectious disease doctor @UCSF. #LongCOVID researcher. #HIV clinician and #HIVcure researcher.

ID: 1499496642709319682

linkhttp://www.liincstudy.org calendar_today03-03-2022 21:28:11

87 Tweet

5,5K Takipçi

73 Takip Edilen

Michael Peluso, MD (@michaelpelusomd) 's Twitter Profile Photo

New UC San Francisco #LIINC paper: immune activation & viral persistence in tissue up to 2 years post-COVID. Found double-stranded RNA in #LongCOVID, suggesting active reservoir persists and evades immune clearance. Thanks PolyBio, NIH for support. Science Translational Medicine science.org/doi/10.1126/sc…

PolyBio (@polybiorf) 's Twitter Profile Photo

Breaking!: Research published today in Science Translational Medicine and supported by PolyBio Research Foundation shows that the #SARS-CoV-2 virus can chronically persist in the gut of patients with long COVID for over 2 years: polybio.org/chronic-virus-…

Patient-Led Research Collaborative (@patientled) 's Twitter Profile Photo

Today, we are thrilled to see the introduction of The Long COVID Research Moonshot Act by Senator Bernie Sanders (Bernie Sanders), co-sponsored by Senators Senator Tim Kaine, Tammy Duckworth, Ed Markey, Senator Peter Welch, and Tina Smith! sanders.senate.gov/wp-content/upl… #LongCovid 1/

Michael Peluso, MD (@michaelpelusomd) 's Twitter Profile Photo

Our new UC San Francisco #FindCOVID/#LIINC paper in Nature Communications showing SCV2 burden in first 3 weeks of COVID predicts future #LongCovid. In addition to LC treatment trials, we need investment in studies to prevent LC! Zero US-based trials on prevention so far. nature.com/articles/s4146…

Our new <a href="/UCSF/">UC San Francisco</a> #FindCOVID/#LIINC paper in <a href="/NatureComms/">Nature Communications</a> showing SCV2 burden in first 3 weeks of COVID predicts future #LongCovid. 

In addition to LC treatment trials, we need investment in studies to prevent LC! Zero US-based trials on prevention so far.

nature.com/articles/s4146…
Michael Peluso, MD (@michaelpelusomd) 's Twitter Profile Photo

Our mechanistic review of #LongCovid - published in Cell - hopefully will be helpful coming out of the very inspiring RECOVER-Treating Long COVID meeting this week. Excited for the progress we will make together in the next year! sciencedirect.com/science/articl…

WesElyMD (@weselymd) 's Twitter Profile Photo

Long Covid Research 💰💰 In our Nature Index piece, Michael Peluso, MD & I expound on different funding avenues for #brainfog…and the dire need for science + answers. Thx to Bec Crew is not here for her wisdom & insight as editor. Read here: go.nature.com/3NgBcC4

Long Covid Research 💰💰

In our <a href="/NatureIndex/">Nature Index</a> piece, <a href="/MichaelPelusoMD/">Michael Peluso, MD</a> &amp; I expound on different funding avenues for #brainfog…and the dire need for science + answers.

Thx to <a href="/BecCrew/">Bec Crew is not here</a> for her wisdom &amp; insight as editor. 

Read here:
go.nature.com/3NgBcC4
Michael Peluso, MD (@michaelpelusomd) 's Twitter Profile Photo

New Clinical Microbiology and Infection study showing association between post-acute SARS-CoV-2 protein in blood and #LongCOVID. Data from 4 cohorts, including #NIHRECOVER and UC San Francisco #LIINC. Need more research ASAP to see if useful as a biomarker for trials!

New <a href="/CMIJournal/">Clinical Microbiology and Infection</a> study showing association between  post-acute SARS-CoV-2 protein in blood and #LongCOVID. Data from 4 cohorts, including #NIHRECOVER and <a href="/UCSF/">UC San Francisco</a> #LIINC. Need more research ASAP to see if useful as a biomarker for trials!
Michael Peluso, MD (@michaelpelusomd) 's Twitter Profile Photo

Excited to share this Science Translational Medicine viewpoint with Maureen Hanson on why #LongCOVID #MECFS and other infection-associated chronic conditions should be studied together as part of a coordinated research agenda. science.org/doi/10.1126/sc…

Excited to share this <a href="/ScienceTM/">Science Translational Medicine</a> viewpoint with <a href="/DrMaureenHanson/">Maureen Hanson</a> on why #LongCOVID #MECFS and other infection-associated chronic conditions should be studied together as part of a coordinated research agenda.

science.org/doi/10.1126/sc…
Michael Peluso, MD (@michaelpelusomd) 's Twitter Profile Photo

New UC San Francisco #LIINC paper shows low mature/cytotoxic NK cells in #LongCovid compared to full recovery. Could reflect inability to clear infection. More interesting data showing immunologic differences in #LongCovid. Thanks to PolyBio NIH for funding. jci.org/articles/view/…

New <a href="/UCSF/">UC San Francisco</a> #LIINC paper shows low mature/cytotoxic NK cells in #LongCovid compared to full recovery. Could reflect inability to clear infection. More interesting data showing immunologic differences in #LongCovid. Thanks to <a href="/polybioRF/">PolyBio</a> <a href="/NIH/">NIH</a> for funding.

jci.org/articles/view/…
Michael Peluso, MD (@michaelpelusomd) 's Twitter Profile Photo

Proud to have been a part of this PolyBio effort to describe the path forward for #LongCOVID trials targeting SARS-CoV-2 persistence. We need a robust biomarker development program and to launch more trials to rigorously test treatments that target these pathways now.